Jungheon Ceftriaxone Sodium Injection 2 grams

Adult administration

Adults and children over 12 years old should receive 1-2g (potency) of ceftriaxone as a single intravenous or intramuscular injection once daily. For infections caused by pathogens with severe disease or moderate sensitivity, the dose may be increased to 4g (potency) once daily. Elderly patients do not require changes to adult dosage and should follow the standard dosage. For gonorrhea treatment, a single intramuscular injection of 250mg (potency) is recommended. Infections before and after surgery.

Child administration

For newborns (within 14 days of birth), administer 20-50mg (potency) per kg of body weight once daily, not exceeding 50mg (potency) per kg. Administer to both premature and full-term infants without distinction. Infants and young children

This medication should not be mixed or administered concurrently with solutions or drugs containing calcium. This is particularly critical for newborns, as co-administration with calcium can form serious precipitates and lead to life-threatening side effects. It should not be administered to patients with hypersensitivity to ceftriaxone or allergies to cephalosporin or penicillin antibiotics. Caution is also required for those allergic to the local anesthetic lidocaine. It may be dangerous for premature infants and newborns with issues related to bilirubin binding. Patients with a history of allergic reactions or asthma symptoms, severe renal impairment, elderly patients, and those in poor general health should exercise special caution when administering this drug, and dose adjustments or additional tests may be necessary. This medication can cause various side effects such as decreased blood cell count, diarrhea, rash, and elevated liver enzymes, so if there are any abnormal symptoms during administration, consult medical personnel immediately. Additionally, severe allergic reactions or shock symptoms may occur, thus patients should be monitored closely after administration. This drug can impact kidney function, necessitating regular liver and kidney function tests, and some patients may form precipitates in the gallbladder, so careful observation for symptoms is required. Consider potential drug interactions when administering this drug, especially when used with diuretics, aminoglycoside antibiotics, and vitamin K antagonists. Women who are pregnant or breastfeeding should exercise caution when administering this medication, and it should not be used in neonates or premature infants due to the risk of bilirubin encephalopathy. Lastly, this medication can cause side effects like dizziness that may affect driving or operating machinery, so caution is needed. Finally, this drug should be used as soon as possible after preparation, and proper temperature conditions should be maintained during storage.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, cold sweat, pallor, high fever with severe rash, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attack, breathing difficulties accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, drastically reduced urine output

Mild side effects

• Eosinophilia
• leukopenia
• thrombocytopenia
• diarrhea
• rash
• elevated liver enzymes
• headache
• dizziness
• bronchospasm
• loose stools

This medication should be stored in a sealed container to avoid exposure to air and kept at room temperature between 1 and 30 degrees Celsius. This storage method maintains the drug's efficacy and prevents degradation.

Appearance

A colorless, transparent vial containing a white to pale yellow powder.

Package unit

10 vials